Browse > Article

Treatment Outcomes of Maxillectomy for Squamous Cell Carcinomas of the Maxillary Sinus  

Jeong Han-Sin (Department of Otorhinolaryngology-Head and Neck Surgery, Sungkyunkwan University School of Medicine, Samsung Medical Center)
Son Young-Ik (Department of Otorhinolaryngology-Head and Neck Surgery, Sungkyunkwan University School of Medicine, Samsung Medical Center)
Chung Man-Ki (Department of Otorhinolaryngology-Head and Neck Surgery, Sungkyunkwan University School of Medicine, Samsung Medical Center)
Min Jin-Young (Department of Otorhinolaryngology-Head and Neck Surgery, Sungkyunkwan University School of Medicine, Samsung Medical Center)
Oh Jae-Won (Department of Otorhinolaryngology-Head and Neck Surgery, Sungkyunkwan University School of Medicine, Samsung Medical Center)
Hong Sang-Duk (Department of Otorhinolaryngology-Head and Neck Surgery, Sungkyunkwan University School of Medicine, Samsung Medical Center)
Lee Hyun-Seok (Department of Otorhinolaryngology-Head and Neck Surgery, Sungkyunkwan University School of Medicine, Samsung Medical Center)
Baek Chung-Hwan (Department of Otorhinolaryngology-Head and Neck Surgery, Sungkyunkwan University School of Medicine, Samsung Medical Center)
Publication Information
Korean Journal of Head & Neck Oncology / v.22, no.1, 2006 , pp. 23-28 More about this Journal
Abstract
Background and Objectives: Maxillectomy is the mainstay of treatment for malignant tumors of the maxillary sinus(MS). Nevertheless, few have been reported on the surgical outcomes of maxillectomy for malignant tumors of MS in Korean literature. Based on our clinical experience, the authors aimed to present the treatment outcomes of maxillectomy for squamous cell carcinomas(SCC) of MS. Subjects and Methods: We reviewed the medical records of 26 cases of maxillectomies with see of MS, who were treated from 1995 to 2004 at Samsung Medical Center. Most patients(73.1%) were locally advanced stage(T3 or T4a) at initial presentation. Total maxillectomy was performed in 18 cases, which is the most frequent procedure(69.2%). We analyzed the treatment outcomes of see of MS and several variables includeing tumor stage and resection margin to identify predictors for treatment failure after maxillectomy. Follow-up duration ranged from 7 to 89 months with a mean of 33 months. Results: Treatment failure occurred in 7 cases(26.9%), among which 3 were salvaged. Three of 26 maxillectomies(11.5%) showed the positive or close(less than 5mm) resection margin in their posterior resection sites; however it did not coincide with the site of recurrence after radiation therapy. Among patients who had been followed up for more than 6 months, disease-free 3 year survival rate was 100.0% in T1 and T2, 76.2% in T3, 60% in T4a, and 69.6% in total. Conclusion: Even though most of see of MS were detected at locally advanced stage, maxillectomy with or without postoperative radiation therapy for resectable MS see(T1-T4a) provided the acceptable treatment outcome(70%, 3Y disease-free survival rate).
Keywords
Treatment outcome; Maxillary sinus neoplasm; Maxillectomy; Squamous cell carcinomas;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Kondo M, Inuyama Y, Ando Y, et al: Patterns of relapse of squamous cell carcinoma of the maxillary sinus. Cancer. 1984;53: 2206-2210   DOI   ScienceOn
2 Jiang GL, Ang KK, Peters LJ, Wendt CD, Oswald MJ, Goepfert H: Maxillary sinus carcinomas: natural history and results of postoperative radiotherapy. Radiother Oncol. 1991;21:193-200   DOI   ScienceOn
3 Yucel A, Cinar C, Aydin Y, et al: Malignant tumors requiring maxillectomy. J Craniofac Surg. 2000;11:418-429   DOI
4 Myers LL, Nussenbaum B, Bradford CR, Teknos TN: Esclamado RM, Wolf GT. Paranasal sinus malignancies: an 18-year single institution experience. Laryngoscope. 2002;112:1964-1969   DOI   ScienceOn
5 Stem SJ, Goepfert H, Clayman G, Byers R, Wolf P: Orbital preservation in maxillectomy. Otolaryngol Head Neck Surg. 1993; 109:111-115   DOI
6 Lavertu P, Roberts JK, Kraus DH, et al: Squamous cell carcinoma of the paranasal sinuses: the Cleveland Clinic experience 1977-1986. Laryngoscope. 1989;99:1130-1136
7 Stern SJ, Goepfert H, Clayman G, et al: Squamous cell carcinoma of the maxillary sinus. Arch Otolaryngol Head Neck Surg. 1993;119:964-969   DOI   ScienceOn
8 Dulguerov P, Jacobsen MS, Allal AS, Lehmann W, Calcaterra T: Nasal and paranasal sinus carcinoma: are we making progress? A series of 220 patients and a systematic review. Cancer. 2001; 92:3012-3029   DOI   ScienceOn
9 Lore JM, Jr: Partial and radical maxillectomy. Otolaryngol Clin North Am. 1976;9:255-267
10 Giri SP, Reddy EK, Gemer LS, Krishnan L, Smalley SR, Evans RG: Management of advanced squamous cell carcinomas of the maxillary sinus. Cancer. 1992;69:657-661   DOI   ScienceOn
11 Choi EC, Choi YS, Kim CH, et al: Surgical outcome of radical maxillectomy in advanced maxillary sinus cancers. Yonsei Med. J 2004;45:621-628   DOI
12 Spiro RH, Strong EW, Shah JP: Maxillectomy and its classification. Head Neck. 1997;19:309-314   DOI   ScienceOn
13 Lindeman P, Eklund U, Petruson B: Survival after surgical treatment in maxillary neoplasms of epithelial origin. J Laryngol Otol. 1987;101:564-568   DOI
14 Blanco AI, Chao KS, Ozyigit G, et al: Carcinoma of paranasal sinuses: long-term outcomes with radiotherapy. Int J Radiat Oncol Biol Phys. 2004;59:51-58   DOI   ScienceOn
15 Hayashi T, Nonaka S, Bandoh N, Kobayashi Y, Imada M, Harabuchi Y: Treatment outcome of maxillary sinus squamous cell carcinoma. Cancer. 2001;92:1495-1503   DOI   ScienceOn
16 Nishino H, Miyata M, Morita M, Ishikawa K, Kanazawa T, Ichimura K: Combined therapy with conservative surgery, radiotherapy, and regional chemotherapy for maxillary sinus carcinoma. Cancer. 2000;89:1925-1932   DOI   ScienceOn
17 Yoshimura R, Shibuya H, Ogura I, et al: Trimodal combination therapy for maxillary sinus carcinama. Int J Radiat Oncol Biol Phys. 2002;53:656-663   DOI   ScienceOn
18 Yao K, Takahashi H, Inagi K, et al: Treatment of maxillary sinus carcinoma: clinical results using the Kitasato modality. Acta Otolaryngol Suppl. 2002:15-19